Gerald Weissmann — physician, editor, and co‑discoverer of liposomes

Early life and career

Weissmann was born in Vienna, where his early life was shaped by the European intellectual milieu before he emigrated to the United States. He maintained connections to his birthplace in later descriptions and interviews. His academic work brought him into the intersecting fields of clinical medicine, basic research, and science communication, establishing him as a teacher, laboratory investigator, and public commentator.

Scientific contributions: liposomes and beyond

In 1965 Weissmann was among the investigators who recognized and developed the concept of liposomes — microscopic, spherical vesicles composed of lipid bilayers. Liposomes became important both as model systems for studying biological membranes and as practical carriers for delivering drugs, vaccines and other therapeutic agents. The development of liposome technology helped open pathways to targeted delivery and sustained release formulations that are now widespread in pharmaceutical research and biotechnology.

Editorial work and writing

Weissmann combined scientific practice with a strong commitment to communication. He served as Editor‑in‑Chief of The FASEB Journal from 2006 to 2016, guiding a major society publication that covers experimental biology. He also wrote essays and editorials aimed at a broad readership, reflecting on medicine, research culture, and ethics in science. His editorial leadership emphasized clarity, rigorous peer review, and the public responsibilities of researchers.

Significance and legacy

Weissmann’s career exemplified a blend of laboratory discovery, clinical perspective, and editorial influence. The liposome work is a durable technical legacy that helped spawn decades of applied research in drug delivery and nanomedicine. His stewardship of scientific discourse through journals and essays contributed to debates about research quality, reproducibility and the role of scientists in society.

Notable facts

• Born in Vienna and identified with both European and American scientific traditions; contextual ties to Austria.
• Professor Emeritus and Research Professor of Medicine (Rheumatology) at New York University School of Medicine.
• Editor‑in‑Chief of The FASEB Journal (2006–2016), shaping a multidisciplinary journal in experimental biology.
• Among the early researchers associated with the discovery and application of liposomes in 1965.
• Died July 10, 2019 in Cambridge, Massachusetts at age 88.

Taken together, Weissmann’s scientific work, editorial service and essays form a cohesive record of engagement with both the methods of biomedical research and the broader cultural questions raised by scientific practice.